Hood River Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,216,040	Closed	-$30.7M	–	162
2025 Q1	$30.7M	Buy	9,216,040 +224,467	+2%	+$1.16M	0.52%	75
2024 Q4	$66.5M	Buy	8,991,573 +846,936	+10%	+$7.85M	0.98%	38
2024 Q3	$76.5M	Buy	8,144,637 +5,412,210	+198%	+$51.3M	1.23%	29
2024 Q2	$21.9M	Buy	2,732,427 +108,189	+4%	+$1.16M	0.45%	79
2024 Q1	$38.9M	Buy	2,624,238 +622,728	+31%	+$7.25M	0.87%	45
2023 Q4	$16.3M	Buy	2,001,510 +9,175	+0.5%	+$48K	0.45%	77
2023 Q3	$9.07M	Buy	1,992,335 +16,784	+0.8%	+$110K	0.29%	84
2023 Q2	$13.9M	Buy	+1,975,551	New	+$14.1M	0.41%	74
2021 Q2	–	Sell	-460,679	Closed	-$14.6M	–	121
2021 Q1	$14.6M	Sell	460,679 -44,732	-9%	-$1.85M	0.47%	80
2020 Q4	$23.5M	Buy	505,411 +8,546	+2%	+$339K	0.78%	57
2020 Q3	$16.4M	Sell	496,865 -50,447	-9%	-$1.55M	0.71%	55
2020 Q2	$15M	Buy	+547,312	New	+$18M	0.67%	60